Immune biomarkers: the promises and pitfalls of personalized medicine. (Q38392912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

3 March 2020

review article

1 reference

title

Immune biomarkers: the promises and pitfalls of personalized medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

3 March 2020

main subject

biomarker

0 references

personalized medicine

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

3 March 2020

Graham M Lord

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Joanna C D Willis

series ordinal

1

1 reference

2 September 2017

Graham M Lord

series ordinal

2

1 reference

2 September 2017

language of work or name

1 reference

27 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

Nature Reviews Immunology

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

3 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

3 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

323-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?

3 March 2020

cites work

1 reference

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

21 January 2018

1 reference

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

Genetic and epigenetic predictors of responsiveness to treatment in RA.

21 January 2018

1 reference

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

21 January 2018

1 reference

Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential

21 January 2018

1 reference

Immune modulation for cancer therapy

21 January 2018

1 reference

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival

21 January 2018

1 reference

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

The immunogenetic architecture of autoimmune disease

21 January 2018

1 reference

Noninvasive diagnosis of acute rejection of renal allografts

21 January 2018

1 reference

Proteogenomic characterization of human colon and rectal cancer

21 January 2018

1 reference

Physiological and pathological roles for microRNAs in the immune system

21 January 2018

1 reference

MicroRNA in autoimmunity and autoimmune diseases.

21 January 2018

1 reference

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

21 January 2018

1 reference

Genome-wide sequencing of cellular microRNAs identifies a combinatorial expression signature diagnostic of sepsis

21 January 2018

1 reference

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

21 January 2018

1 reference

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

The pits and pearls in translating operational tolerance biomarkers into clinical practice

21 January 2018

1 reference

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

21 January 2018

1 reference

Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology

21 January 2018

1 reference

Validation of a blood protein signature for non-small cell lung cancer

21 January 2018

1 reference

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

21 January 2018

1 reference

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

21 January 2018

1 reference

Current concepts in the diagnosis and management of cytokine release syndrome

21 January 2018

1 reference

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.

21 January 2018

1 reference

Biomarkers for kidney transplant rejection

21 January 2018

1 reference

Systems immunology: a survey of modeling formalisms, applications and simulation tools

21 January 2018

1 reference

Integration of lyoplate based flow cytometry and computational analysis for standardized immunological biomarker discovery.

21 January 2018

1 reference

Weighing in on autoimmune disease: Big data tip the scale.

21 January 2018

1 reference

Net risk reclassification p values: valid or misleading?

21 January 2018

1 reference

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

21 January 2018

1 reference

Genomics and privacy: implications of the new reality of closed data for the field

21 January 2018

1 reference

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in t

21 January 2018

1 reference

Downsizing genomic medicine: approaching the ethical complexity of whole-genome sequencing by starting small

21 January 2018

1 reference

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

21 January 2018

1 reference

Immunology. Regulatory T cells get their chance to shine

21 January 2018

1 reference

Circulating Proteomic Signatures of Chronological Age.

31 March 2020

1 reference

Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes

31 March 2020

1 reference

Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25814400

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25814400

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Environment and Disease: Association or Causation?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25814400

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRI3820

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814400 AND SRC:MED&resulttype=core&format=json

3 March 2020

1 reference